The role of suppressor of cytokine signalling-3 (SOCS-3) in chondrocytes during development and disease
The role of suppressor of cytokine signalling-3 (SOCS-3) in chondrocytes during development and disease
批准号:
nhmrc : 406645
负责人:
Dr Ian Campbell
金额:
$23.23万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytokines are messenger proteins produced and secreted from one cell which then bind to specific receptors on the surface of other cells. After binding, a series of intracellular events occurs, termed signalling, that results in the target cell changing its behaviour. Cytokine signalling, if allowed to proceed unchecked, can result in various disease states. The suppressor of cytokine signalling (SOCS) proteins are key negative regulators of cytokine signalling within the cell. They are induced by a wide range of stimuli, especially from a group called the IL-6 family. We have preliminary data showing that cartilage cells (chondrocytes) normally produce a particular SOCS protein, called SOCS-3. We have also shown that when SOCS-3 production is dysregulated, the chondrocytes undergo excessive proliferation. Normal chondrocyte function is important during skeletal development and diseases such as osteoarthritis are thought to result from abnormal chondrocyte behaviour. It is likely that SOCS-3 has a key role in regulating chondrocyte function. The aim of this proposal is therefore to examine the role of SOCS-3 in chondrocytes, during development and in disease. Much of our understanding of the role of the SOCS proteins comes from the construction of mutant mice that lack a particular SOCS protein. When mutant mice are made that lack SOCS-3 in the whole animal the mice die before birth and so virtually nothing is known about the role of SOCS-3 in chondrocytes and the implications for cartilage in disease states, such as arthritis. To answer this we will create mice that lack SOCS-3 specifically in their chondrocytes. Evaluating the role of SOCS-3 in cartilage development and chondrocyte function during degenerative and inflammatory disease states is potentially of major clinical importance in improving our understanding of arthritis and of cartilage repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and pre-clinical testing of a novel G-CSF antagonista for the treatment of inflammatory diseases
-
批准号:nhmrc : 461287
-
项目类别:Early Career Fellowships
-
资助金额:$25.39万
-
财政年份:2007
-
负责人:Dr Ian Campbell
-
依托单位:
Development and pre-clinical evaluation of G-DSF inhibitors for inflammatory joint disease
-
批准号:nhmrc : 305558
-
项目类别:NHMRC Development Grants
-
资助金额:$5.89万
-
财政年份:2005
-
负责人:Dr Ian Campbell
-
依托单位:
The role of SOCS-1 and SOCS-3 in regulating acute inflammatory arthritis.
-
批准号:nhmrc : 305523
-
项目类别:NHMRC Project Grants
-
资助金额:$29.67万
-
财政年份:2004
-
负责人:Dr Ian Campbell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
抑制性tRNA(suppressor tRNA, sup-tRNA)通读CFTR无义突变治疗囊性纤维化疾病小鼠的研究
-
批准号:82370099
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:陈璋辉
-
依托单位:
拟南芥COP1 SUPPRESSOR 6调控光形态建成的的分子机理研究
-
批准号:32100199
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:衡月芹
-
依托单位:
UBIAD1调控Ras信号的机制研究
-
批准号:32100587
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:许志亮
-
依托单位:
利用新型突变p53蛋白水平报告基因小鼠模型研究胸腺T细胞淋巴瘤恶性转化的早期事件
-
批准号:32000554
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:姚朋乐
-
依托单位:
Rox8/TIAL1调控Hippo信号通路的机制研究
-
批准号:32000547
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郭晓伟
-
依托单位:
同义突变调控APC蛋白生物学功能及结直肠癌的发生发展
-
批准号:32000539
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:潘晨宇
-
依托单位:
YY2因子在肿瘤细胞染色体不稳定性调控中的生物学机制研究
-
批准号:32070715
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:江启慧
-
依托单位:
DNA结合抑制因子ID4在H.pylori相关胃癌发展中的关键调控机制研究
-
批准号:31970728
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:郏雁飞
-
依托单位:
KLF14翻译后修饰及其在调控肿瘤细胞死亡中的作用研究
-
批准号:31970736
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:王传贵
-
依托单位:
果蝇FRMD5调节Hippo信号通路活性与组织生长的分子机制研究
-
批准号:31970733
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:吴世安
-
依托单位: